You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Papillary renal cell carcinoma type 1

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Renal Cell Carcinoma, Papillary Renal Cell Carcinoma Type 1, Papillary Renal Cell Carcinoma Type 2 Trial in Australia

Recruiting
  • Renal Cell Carcinoma
  • +5 more
  • Albury, New South Wales, Australia
  • +10 more
Feb 14, 2022

Renal Cell Carcinoma, Papillary Renal Cell Carcinoma Type 1, Papillary Renal Cell Carcinoma Type 2 Trial in Australia

Active, not recruiting
  • Renal Cell Carcinoma
  • +5 more
  • Albury, New South Wales, Australia
  • +18 more
Feb 14, 2022

Advanced Clear Cell Renal Carcinoma (Ccrcc), Papillary Renal Cell Carcinoma (Prcc) Trial run by the National Cancer Institute

Not yet recruiting
  • Advanced Clear Cell Renal Carcinoma (Ccrcc)
  • Papillary Renal Cell Carcinoma (Prcc)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Papillary Renal Cell Carcinoma Trial (Pembrolizumab, Placebo)

Not yet recruiting
  • Papillary Renal Cell Carcinoma
  • (no location specified)
Nov 24, 2023

Locally Advanced and/or Metastatic Anaplastic Large Cell Lymphoma, Locally Advanced and/or Metastatic Inflammatory

Active, not recruiting
  • Locally Advanced and/or Metastatic Anaplastic Large Cell Lymphoma
  • +5 more
  • Crizotinib (PF-02341066)
  • Brussels, Belgium
  • +24 more
May 9, 2022

Clinical Factors on Prognosis of Papillary Renal Cell Carcinoma

Completed
  • Carcinoma, Renal Cell
  • We do not have any interventions. This study is based on obseravation.
  • (no location specified)
Oct 27, 2023

Papillary Renal Cell Carcinoma Type 2 Trial in France (Axitinib Oral Tablet [Inlyta], Pembrolizumab Injection [Keytruda])

Recruiting
  • Papillary Renal Cell Carcinoma Type 2
  • Axitinib Oral Tablet [Inlyta]
  • Pembrolizumab Injection [Keytruda]
  • Angers, France
  • +11 more
Aug 26, 2022

Carcinoma, Renal Cell Trial (Orellanine)

Not yet recruiting
  • Carcinoma, Renal Cell
  • (no location specified)
Jan 25, 2023

Renal Clear Cell Carcinoma, Renal Papillary Cell Carcinoma Trial in London (Savolitinib, MEDI4736, Tremelimumab)

Active, not recruiting
  • Renal Clear Cell Carcinoma
  • Renal Papillary Cell Carcinoma
  • London, United Kingdom
    Thomas Powles
Aug 10, 2022

Kidney Cancer Trial run by the NCI (INC280)

Completed
  • Kidney Cancer
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 18, 2021

Clear Cell Kidney Cancer, Kidney Cancer, Kidney Cancer With PBRM1/BAP1/VHL/SETD2 Mutations Trial (Axitinib 5 MG)

Available
  • Clear Cell Kidney Cancer
  • +2 more
  • Axitinib 5 MG
  • (no location specified)
Jul 3, 2023

Advanced Clear Cell Renal Cell Carcinoma, Advanced Papillary Renal Cell Carcinoma, Advanced Renal Cell Carcinoma Trial in Duarte

Recruiting
  • Advanced Clear Cell Renal Cell Carcinoma
  • +11 more
  • Cabozantinib S-malate
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Nov 22, 2022

Clear Cell Renal Cell Carcinoma?Resistance to Immunotherapy Trial in Shanghai (AK104(anti-PD-1/CTLA-4 bi-specific antibody

Recruiting
  • Clear Cell Renal Cell Carcinoma、Resistance to Immunotherapy
  • AK104（anti-PD-1/CTLA-4 bi-specific antibody ，intravenously）,lenvatinib（ targeted VEGFR 1-3、FGFR、PDGFRα， small molecule TKI，orally
  • Shanghai, Shanghai, China
    Shanghai Renji Hospital
Sep 12, 2023

Clear Cell Papillary Renal Tumor, Collecting Duct Carcinoma, Hereditary Leiomyomatosis and Renal Cell Carcinoma Trial in Los

Recruiting
  • Clear Cell Papillary Renal Neoplasm
  • +10 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Oct 25, 2021

Sutureless Zero Ischemia Laparoscopic Tumor Enucleation for T1

Recruiting
  • Carcinoma, Renal Cell
  • Kidney Neoplasms
    • Yiwu, Zhejiang, China
      The Fourth Affiliated Hospital Zhejiang University School of Med
    Mar 27, 2023

    Renal Cell Carcinoma Trial in Tabriz (Sodium Pentaborate)

    Not yet recruiting
    • Renal Cell Carcinoma
    • Sodium Pentaborate
    • Tabriz, East Azarbayejan, Iran, Islamic Republic of
      Imam Reza hospital and Clinic of Salamat
    Mar 23, 2023

    Kidney Cancer, Renal Cell Carcinoma, Clear Cell Carcinoma Trial in Dallas (13C-Glucose, 13C-Acetate, 13C-Lactate)

    Recruiting
    • Kidney Cancer
    • +11 more
    • 13C-Glucose
    • +4 more
    • Dallas, Texas
      University of Texas Southwestern Medical Center
    Dec 1, 2022

    Metastatic Papillary Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v8 Trial (Atezolizumab, Cabozantinib S-malate)

    Recruiting
    • Metastatic Papillary Renal Cell Carcinoma
    • Stage IV Renal Cell Cancer AJCC v8
    • Atezolizumab
    • +4 more
    • Sacramento, California
    • +38 more
    Jan 17, 2023

    Renal Cell Carcinoma, Neoadjuvant Trial (Axitinib plus Toripalimab, radical nephrectomy)

    Not yet recruiting
    • Renal Cell Carcinoma
    • Neoadjuvant
    • Axitinib plus Toripalimab
    • radical nephrectomy
    • (no location specified)
    Feb 12, 2023

    Clear Cell Renal Cell Carcinoma, Solid Tumors Trial (AB521)

    Not yet recruiting
    • Clear Cell Renal Cell Carcinoma
    • Solid Tumors
    • (no location specified)
    Sep 7, 2022

    Primary and Metastatic Tumors in Renal Cell Carcinoma and

    Recruiting
    • Renal Cell Carcinoma
    • +4 more
    • Immune checkpoint inhibitor targeting PD1
    • Philadelphia, Pennsylvania
      Fox Chase Cancer Center - Philadelphia
    Jan 27, 2023

    Non-clear Renal Cell Carcinoma Trial in Nanjing, Nanning (Toripalimab, Axitinib)

    Recruiting
    • Non-clear Renal Cell Carcinoma
    • Nanjing, Jiangsu, China
    • +1 more
    Mar 13, 2023

    Among Advanced Renal Cell Carcinoma Receiving Systemic

    Not yet recruiting
    • Carcinoma, Renal Cell
      • (no location specified)
      Sep 6, 2022

      Urothelial Carcinoma, Renal Cell Carcinoma, Melanoma Trial (BGB-A445, Tislelizumab)

      Not yet recruiting
      • Urothelial Carcinoma
      • +2 more
      • (no location specified)
      Dec 15, 2022

      Non-Clear Cell Renal Cell Carcinoma Trial in Duarte (XL092, Nivolumab, Sunitinib Malate)

      Recruiting
      • Non-Clear Cell Renal Cell Carcinoma
      • Duarte, California
        Exelixis Clinical Site #1
      Jan 13, 2023